Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-7-10
pubmed:abstractText
To evaluate macular thickness measured by optical coherence tomography (OCT) during pegaptanib therapy for neovascular age-related macular degeneration (AMD).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0275-004X
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
724-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17621181-Aged, pubmed-meshheading:17621181-Aged, 80 and over, pubmed-meshheading:17621181-Angiogenesis Inhibitors, pubmed-meshheading:17621181-Aptamers, Nucleotide, pubmed-meshheading:17621181-Choroidal Neovascularization, pubmed-meshheading:17621181-Female, pubmed-meshheading:17621181-Fluorescein Angiography, pubmed-meshheading:17621181-Follow-Up Studies, pubmed-meshheading:17621181-Fovea Centralis, pubmed-meshheading:17621181-Humans, pubmed-meshheading:17621181-Injections, pubmed-meshheading:17621181-Macular Degeneration, pubmed-meshheading:17621181-Macular Edema, pubmed-meshheading:17621181-Male, pubmed-meshheading:17621181-Middle Aged, pubmed-meshheading:17621181-Prospective Studies, pubmed-meshheading:17621181-Tomography, Optical Coherence, pubmed-meshheading:17621181-Vascular Endothelial Growth Factor A, pubmed-meshheading:17621181-Vitreous Body
pubmed:articleTitle
Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration.
pubmed:affiliation
Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't